Apexian Pharmaceuticals' Series A - II Round

Apexian Pharmaceuticals raised a round of funding on June 24, 2015. Investors include Pearl Street Ventures.

Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/R…

Articles about Apexian Pharmaceuticals' Series A - II Round: